Leonovus Inc.
LVNSF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | -93.6% | -76.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | -3,540% | 100% | 100% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $3 | $2 |
| Operating Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | -36,120% | -3,107.7% | -517.1% |
| Other Income/Exp. Net | $1 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$3 | -$3 | -$2 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$0 | -$3 | -$3 | -$2 |
| % Margin | – | -61,760% | -3,309% | -551.1% |
| EPS | -0.003 | -0.15 | -0.14 | -0.19 |
| % Growth | 98.3% | -7.1% | 26.3% | – |
| EPS Diluted | -0.003 | -0.15 | -0.14 | -0.19 |
| Weighted Avg Shares Out | 21 | 21 | 19 | 10 |
| Weighted Avg Shares Out Dil | 21 | 21 | 19 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | -$0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$3 | -$2 | -$1 |
| % Margin | – | -55,780% | -2,920.5% | -434.6% |